Identification of Novel Disease Drivers, Therapeutic Targets, and Biomarkers of Sepsis
Identification of Novel Disease Drivers, Therapeutic Targets, and Biomarkers of Sepsis
批准号:
484160
负责人:
Lu Kun Ping
金额:
$7.29万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2023
资助国家:
加拿大
项目状态:
已结题
起止时间:
2023-03-01 至 2024-03-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Sepsis refers to the body's exaggerated response to infection. Fifty million people develop sepsis annually, leading to one-fifth of all global deaths. Sepsis results in a life-threatening and abrupt release of small inflammatory molecules called cytokine
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Optimized Reversible Pin1 Inhibitors to Block Multiple Cancer-Driving Pathways and to Disrupt Immunosuppressive Tumor Microenvironment
-
批准号:494870
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2023
-
负责人:Lu Kun Ping
-
依托单位:
Identification of Novel Disease Drivers, Therapeutic Targets, and Biomarkers of Sepsis
-
批准号:494277
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2023
-
负责人:Lu Kun Ping
-
依托单位:
海外基金